Mycophenolate Sodium

JUL 29, 2026 · REGULATORY LABEL UPDATE

FDA supplemental approval: Mycophenolate Sodium (REMS)

U.S. Food and Drug Administration

FDA supplemental approval of a Risk Evaluation and Mitigation Strategy (REMS) for an existing immunosuppressant; indicates regulatory action on safety management, not new clinical efficacy evidence.